IBDEI0NM ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10512,0)
 ;;=H21.1X2^^74^681^38
 ;;^UTILITY(U,$J,358.3,10512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10512,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Lt Eye
 ;;^UTILITY(U,$J,358.3,10512,1,4,0)
 ;;=4^H21.1X2
 ;;^UTILITY(U,$J,358.3,10512,2)
 ;;=^5005176
 ;;^UTILITY(U,$J,358.3,10513,0)
 ;;=H21.1X3^^74^681^39
 ;;^UTILITY(U,$J,358.3,10513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10513,1,3,0)
 ;;=3^Vascular Disorders of Iris & Ciliary Body,Bilateral
 ;;^UTILITY(U,$J,358.3,10513,1,4,0)
 ;;=4^H21.1X3
 ;;^UTILITY(U,$J,358.3,10513,2)
 ;;=^5005177
 ;;^UTILITY(U,$J,358.3,10514,0)
 ;;=H40.051^^74^682^1
 ;;^UTILITY(U,$J,358.3,10514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10514,1,3,0)
 ;;=3^Ocular Hypertension,Right Eye
 ;;^UTILITY(U,$J,358.3,10514,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,10514,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,10515,0)
 ;;=H40.052^^74^682^2
 ;;^UTILITY(U,$J,358.3,10515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10515,1,3,0)
 ;;=3^Ocular Hypertension,Left Eye
 ;;^UTILITY(U,$J,358.3,10515,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,10515,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,10516,0)
 ;;=H40.053^^74^682^3
 ;;^UTILITY(U,$J,358.3,10516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10516,1,3,0)
 ;;=3^Ocular Hypertension,Bilateral
 ;;^UTILITY(U,$J,358.3,10516,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,10516,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,10517,0)
 ;;=H40.1211^^74^682^16
 ;;^UTILITY(U,$J,358.3,10517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10517,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Right Eye
 ;;^UTILITY(U,$J,358.3,10517,1,4,0)
 ;;=4^H40.1211
 ;;^UTILITY(U,$J,358.3,10517,2)
 ;;=^5005759
 ;;^UTILITY(U,$J,358.3,10518,0)
 ;;=H40.1221^^74^682^17
 ;;^UTILITY(U,$J,358.3,10518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10518,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Left Eye
 ;;^UTILITY(U,$J,358.3,10518,1,4,0)
 ;;=4^H40.1221
 ;;^UTILITY(U,$J,358.3,10518,2)
 ;;=^5005764
 ;;^UTILITY(U,$J,358.3,10519,0)
 ;;=H40.1231^^74^682^18
 ;;^UTILITY(U,$J,358.3,10519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10519,1,3,0)
 ;;=3^Low-Tension Glaucoma,Mild,Bilateral
 ;;^UTILITY(U,$J,358.3,10519,1,4,0)
 ;;=4^H40.1231
 ;;^UTILITY(U,$J,358.3,10519,2)
 ;;=^5005768
 ;;^UTILITY(U,$J,358.3,10520,0)
 ;;=H40.1233^^74^682^20
 ;;^UTILITY(U,$J,358.3,10520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10520,1,3,0)
 ;;=3^Low-Tension Glaucoma,Severe,Bilateral
 ;;^UTILITY(U,$J,358.3,10520,1,4,0)
 ;;=4^H40.1233
 ;;^UTILITY(U,$J,358.3,10520,2)
 ;;=^5005770
 ;;^UTILITY(U,$J,358.3,10521,0)
 ;;=H40.011^^74^682^21
 ;;^UTILITY(U,$J,358.3,10521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10521,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,10521,1,4,0)
 ;;=4^H40.011
 ;;^UTILITY(U,$J,358.3,10521,2)
 ;;=^5005724
 ;;^UTILITY(U,$J,358.3,10522,0)
 ;;=H40.012^^74^682^22
 ;;^UTILITY(U,$J,358.3,10522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10522,1,3,0)
 ;;=3^Open Angle w/ Borderline Findings,Low Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,10522,1,4,0)
 ;;=4^H40.012
 ;;^UTILITY(U,$J,358.3,10522,2)
 ;;=^5005725
 ;;^UTILITY(U,$J,358.3,10523,0)
 ;;=H59.41^^74^682^25
 ;;^UTILITY(U,$J,358.3,10523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10523,1,3,0)
 ;;=3^Blebitis,Stage 1
 ;;^UTILITY(U,$J,358.3,10523,1,4,0)
 ;;=4^H59.41
 ;;^UTILITY(U,$J,358.3,10523,2)
 ;;=^5006426
